C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/52 (2006.01) A61K 38/19 (2006.01) A61P 35/00 (2006.01) C07K 14/525 (2006.01) C07K 14/705 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12N 15/19 (2006.01) C12N 15/28 (2006.01)
Patent
CA 2318029
A novel cytokine, designated Apo-2 ligand, which induces mammalian cancer cell apoptosis is provided. The Apo-2 ligand is believed to be a member of the TNF cytokine family. Compositions including Apo- 2 ligand chimeras, nucleic acid encoding Apo-2 ligand, and antibodies to Apo-2 ligand are also provided. Methods of using Apo-2 ligand to induce apoptosis and to treat pathological conditions such as cancer, are further provided.
La présente invention concerne une nouvelle cytokine, appelée Apo-2 ligand, qui provoque l'apoptose des cellules cancéreuses mammifères. On pense par ailleurs que l'Apo-2 ligand fait partie de la famille des cytokines TNF. De même, cette invention concerne des chimères de l'APo-2 ligand, un acide nucléique codant l'Apo-2 ligand ainsi que des anticorps de l'Apo-2 ligand. Enfin, l'invention concerne des procédés d'utilisation de l'Apo-2 ligand pour induire l'apoptose des cellules cancéreuses et pour traiter les états pathologiques tels que le cancer.
Ashkenazi Avi J.
Kelley Robert F.
O'connell Mark P.
Pitti Robert M.
Schwall Ralph H.
Dennison Associates
Genentech Inc.
LandOfFree
Apo-2 ligand does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apo-2 ligand, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apo-2 ligand will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1677468